Circulating exosomes from patients with coronary syndrome inhibit angiogenesis and trigger inflammatory pathways in vitro through TLR activation

28 August 2018 (15:15 - 15:29)
Organised by:
Congress Presentation Part of: Exosomes: new players in cardiovascular disease Microvesicles, Exosomes ESC Premium Access ESC Congress 2018

ESC 365 is supported by

ESC 365 is supported by